BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26142905)

  • 1. CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.
    Liu RZ; Garcia E; Glubrecht DD; Poon HY; Mackey JR; Godbout R
    Mol Cancer; 2015 Jul; 14():129. PubMed ID: 26142905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRABP1 and CRABP2 Protein Levels Correlate with Each Other but Do Not Correlate with Sensitivity of Breast Cancer Cells to Retinoic Acid.
    Enikeev AD; Komelkov AV; Axelrod ME; Galetsky SA; Kuzmichev SA; Tchevkina EM
    Biochemistry (Mosc); 2021 Feb; 86(2):217-229. PubMed ID: 33832420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of FABP5 expression with poor survival in triple-negative breast cancer: implication for retinoic acid therapy.
    Liu RZ; Graham K; Glubrecht DD; Germain DR; Mackey JR; Godbout R
    Am J Pathol; 2011 Mar; 178(3):997-1008. PubMed ID: 21356353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite Effects of CRABP1 and CRABP2 Homologs on Proliferation of Breast Cancer Cells and Their Sensitivity to Retinoic Acid.
    Enikeev AD; Abramov PM; Elkin DS; Komelkov AV; Beliaeva AA; Silantieva DM; Tchevkina EM
    Biochemistry (Mosc); 2023 Dec; 88(12):2107-2124. PubMed ID: 38462454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status.
    Feng X; Zhang M; Wang B; Zhou C; Mu Y; Li J; Liu X; Wang Y; Song Z; Liu P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):361. PubMed ID: 31419991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
    Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH
    Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cytoplasmic CRABP2, altered retinoic acid signaling, and poor prognosis in glioblastoma.
    Liu RZ; Li S; Garcia E; Glubrecht DD; Poon HY; Easaw JC; Godbout R
    Glia; 2016 Jun; 64(6):963-76. PubMed ID: 26893190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the CRABPII/RAR pathway by curcumin induces retinoic acid mediated apoptosis in retinoic acid resistant breast cancer cells.
    Thulasiraman P; Garriga G; Danthuluri V; McAndrews DJ; Mohiuddin IQ
    Oncol Rep; 2017 Apr; 37(4):2007-2015. PubMed ID: 28350049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic regulation of retinoic acid-binding proteins in developing, adult and neoplastic skin reveals roles for beta-catenin and Notch signalling.
    Collins CA; Watt FM
    Dev Biol; 2008 Dec; 324(1):55-67. PubMed ID: 18805411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L; Gudas LJ
    J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling.
    Zhang W; Levi L; Banerjee P; Jain M; Noy N
    Oncotarget; 2015 Nov; 6(34):35830-42. PubMed ID: 26416422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling.
    Donato LJ; Suh JH; Noy N
    Cancer Res; 2007 Jan; 67(2):609-15. PubMed ID: 17234770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular determinants of retinoic acid sensitivity in pancreatic cancer.
    Gupta S; Pramanik D; Mukherjee R; Campbell NR; Elumalai S; de Wilde RF; Hong SM; Goggins MG; De Jesus-Acosta A; Laheru D; Maitra A
    Clin Cancer Res; 2012 Jan; 18(1):280-9. PubMed ID: 22010213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
    Rubin M; Fenig E; Rosenauer A; Menendez-Botet C; Achkar C; Bentel JM; Yahalom J; Mendelsohn J; Miller WH
    Cancer Res; 1994 Dec; 54(24):6549-56. PubMed ID: 7987855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of influential proteins in the classical retinoic acid signaling pathway.
    Ghaffari H; Petzold LR
    Theor Biol Med Model; 2018 Oct; 15(1):16. PubMed ID: 30322383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid receptor alpha 1 isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells.
    van der Leede BJ; Folkers GE; van den Brink CE; van der Saag PT; van der Burg B
    Mol Cell Endocrinol; 1995 Mar; 109(1):77-86. PubMed ID: 7789618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RAR alpha gene expression and sensitivity to growth inhibition by retinoic acid.
    Sheikh MS; Shao ZM; Chen JC; Hussain A; Jetten AM; Fontana JA
    J Cell Biochem; 1993 Dec; 53(4):394-404. PubMed ID: 8300756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Growth inhibitory effect of retinoic acid in human breast cancer cells correlates with retinoic acid receptor alpha (RAR alpha) expression].
    Yu L; Shao Z; Cai S
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):429-32. PubMed ID: 9387294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of mammary carcinoma growth by retinoic acid: proapoptotic genes are targets for retinoic acid receptor and cellular retinoic acid-binding protein II signaling.
    Donato LJ; Noy N
    Cancer Res; 2005 Sep; 65(18):8193-9. PubMed ID: 16166294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.